{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:06:43Z","timestamp":1792508803896,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:00:00Z","timestamp":1670284800000},"content-version":"vor","delay-in-days":3871,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1111\/j.1538-7836.2012.04674.x","type":"journal-article","created":{"date-parts":[[2012,2,28]],"date-time":"2012-02-28T08:42:53Z","timestamp":1330418573000},"page":"791-798","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":121,"title":["Complement activation in thrombotic thrombocytopenic purpura"],"prefix":"10.1016","volume":"10","author":[{"given":"M.","family":"R\u00c9TI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"FARKAS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"CSUKA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"R\u00c1ZS\u00d3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1.","family":"SCHLAMMADINGER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.L.","family":"UDVARDY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"MAD\u00c1CH","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"DOMJ\u00c1N","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"BERECZKI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.S.","family":"REUSZ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.J.","family":"SZAB\u00d3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"PROH\u00c1SZKA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2012.04674.x_bb0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1182\/blood-2008-02-078170","article-title":"von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura","volume":"112","author":"Sadler","year":"2008","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04674.x_bb0015","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1752-8062.2009.00142.x","article-title":"Thrombotic microangiopathies: multimers, metalloprotease, and beyond","volume":"2","author":"Moake","year":"2009","journal-title":"Clin Transl Sci"},{"key":"10.1111\/j.1538-7836.2012.04674.x_bb0020","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","article-title":"Antibodies to von Willebrand factor\u2010cleaving protease in acute thrombotic thrombocytopenic purpura","volume":"339","author":"Tsai","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2012.04674.x_bb0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/humu.21143","article-title":"ADAMTS13 mutations and polymorphisms in congenital thrombotic thrombocytopenic purpura","volume":"31","author":"Lotta","year":"2010","journal-title":"Hum Mutat"},{"key":"10.1111\/j.1538-7836.2012.04674.x_bb0030","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3324\/haematol.2008.002493","article-title":"Inherited thrombotic thrombocytopenic purpura","volume":"94","author":"Galbusera","year":"2009","journal-title":"Haematologica"},{"key":"10.1111\/j.1538-7836.2012.04674.x_bb0035","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1046\/j.1365-2141.1999.01751.x","article-title":"Characterization of platelet glycoproteins and platelet\/endothelial cell antibodies in patients with thrombotic thrombocytopenic purpura","volume":"107","author":"Wright","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2012.04674.x_bb0040","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1160\/TH04-07-0450","article-title":"Complement activation: the missing link between ADAMTS\u201013 deficiency and microvascular thrombosis of thrombotic microangiopathies","volume":"93","author":"Ruiz\u2010Torres","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2012.04674.x_bb0045","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/BF01956145","article-title":"Evaluation of complement activation in premature newborn infants with hyaline membrane disease","volume":"152","author":"Cat","year":"1993","journal-title":"Eur J Pediatr"},{"key":"10.1111\/j.1538-7836.2012.04674.x_bb0050","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.clim.2011.01.003","article-title":"Parameters of the classical complement pathway predict disease severity in hereditary angioedema","volume":"139","author":"Csuka","year":"2011","journal-title":"Clin Immunol"},{"key":"10.1111\/j.1538-7836.2012.04674.x_bb0055","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1160\/TH09-01-0036","article-title":"Levels of von Willebrand factor antigen and von Willebrand factor cleaving protease (ADAMTS13) activity predict clinical events in chronic heart failure","volume":"102","author":"Gombos","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2012.04674.x_bb0060","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1096\/fj.02-0737com","article-title":"Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells","volume":"17","author":"Monsinjon","year":"2003","journal-title":"Faseb J"},{"key":"10.1111\/j.1538-7836.2012.04674.x_bb0065","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1084\/jem.185.9.1619","article-title":"The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity","volume":"185","author":"Tedesco","year":"1997","journal-title":"J Exp Med"},{"key":"10.1111\/j.1538-7836.2012.04674.x_bb0070","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1182\/blood-2010-05-283564","article-title":"Complement alternative pathway acts as a positive feedback amplification of neutrophil activation","volume":"117","author":"Camous","year":"2011","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04674.x_bb0075","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1203\/01.PDR.0000150725.78971.30","article-title":"Complement C5a is a key mediator of meconium\u2010induced neutrophil activation","volume":"57","author":"Castellheim","year":"2005","journal-title":"Pediatr Res"},{"key":"10.1111\/j.1538-7836.2012.04674.x_bb0080","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/0167-5699(91)90012-I","article-title":"The response of human platelets to activated components of the complement system","volume":"12","author":"Sims","year":"1991","journal-title":"Immunol Today"},{"key":"10.1111\/j.1538-7836.2012.04674.x_bb0085","doi-asserted-by":"crossref","first-page":"13674","DOI":"10.1016\/S0021-9258(19)76479-5","article-title":"Complement C5b\u20109\u2010stimulated platelet secretion is associated with a Ca2+\u2010initiated activation of cellular protein kinases","volume":"262","author":"Wiedmer","year":"1987","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1538-7836.2012.04674.x_bb0090","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1182\/blood.V60.4.1030.1030","article-title":"Pathologic effects of plasma from patients with thrombotic thrombocytopenic purpura on platelets and cultured vascular endothelial cells","volume":"60","author":"Burns","year":"1982","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04674.x_bb0095","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0049-3848(98)00151-0","article-title":"Plasma from a patient with thrombotic thrombocytopenic purpura induces endothelial cell apoptosis and platelet aggregation","volume":"93","author":"Wu","year":"1999","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2012.04674.x_bb0100","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1182\/blood.V93.4.1264","article-title":"Enhanced endothelial cell apoptosis in splenic tissues of patients with thrombotic thrombocytopenic purpura","volume":"93","author":"Dang","year":"1999","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04674.x_bb0105","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1182\/blood.V89.4.1224","article-title":"Thrombotic thrombocytopenic purpura and sporadic hemolytic\u2010uremic syndrome plasmas induce apoptosis in restricted lineages of human microvascular endothelial cells","volume":"89","author":"Mitra","year":"1997","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04674.x_bb0110","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1046\/j.1365-2141.2003.04030.x","article-title":"Plasma from patients with thrombotic thrombocytopenic purpura induces activation of human monocytes and polymorphonuclear neutrophils","volume":"120","author":"Alvarez\u2010Larran","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2012.04674.x_bb0115","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1046\/j.1365-2141.1998.00526.x","article-title":"Thrombotic thrombocytopenic purpura plasma enhances platelet\u2010leucocyte interaction in vitro","volume":"100","author":"Valant","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2012.04674.x_bb0120","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/0891693042000196183","article-title":"Complement activation by apoptotic cells occurs predominantly via IgM and is limited to late apoptotic (secondary necrotic) cells","volume":"37","author":"Zwart","year":"2004","journal-title":"Autoimmunity"},{"key":"10.1111\/j.1538-7836.2012.04674.x_bb0125","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1002\/1521-4141(200206)32:6<1726::AID-IMMU1726>3.0.CO;2-R","article-title":"Direct binding of C1q to apoptotic cells and cell blebs induces complement activation","volume":"32","author":"Nauta","year":"2002","journal-title":"Eur J Immunol"},{"key":"10.1111\/j.1538-7836.2012.04674.x_bb0130","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1111\/j.1538-7836.2009.03568.x","article-title":"IgG subclass distribution of anti\u2010ADAMTS13 antibodies in patients with acquired thrombotic thrombocytopenic purpura","volume":"7","author":"Ferrari","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2012.04674.x_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.1991.tb08115.x","article-title":"The effect of antibody isotype and antigenic epitope density on the complement\u2010fixing activity of immune complexes: a systematic study using chimaeric anti\u2010NIP antibodies with human Fc regions","volume":"84","author":"Lucisano Valim","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/j.1538-7836.2012.04674.x_bb0140","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1182\/blood-2006-02-006064","article-title":"Prognostic value of anti\u2010ADAMTS 13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS 13 activity","volume":"109","author":"Ferrari","year":"2007","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04674.x_bb0145","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1538-7836.2011.04548.x","article-title":"Inverse correlation of free and immune complex\u2010sequestered anti\u2010ADAMTS13 antibodies in a patient with acquired thrombotic thrombocytopenic purpura","volume":"10","author":"Ferrari","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2012.04674.x_bb0150","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1681\/ASN.2005010086","article-title":"Complement factor H mutation in familial thrombotic thrombocytopenic purpura with ADAMTS13 deficiency and renal involvement","volume":"16","author":"Noris","year":"2005","journal-title":"J Am Soc Nephrol"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2012.04674.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622062596?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622062596?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2012.04674.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:58:50Z","timestamp":1761533930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622062596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S1538783622062596"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2012.04674.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complement activation in thrombotic thrombocytopenic purpura","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2012.04674.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}